Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-106460
Filing Date
2021-04-05
Accepted
2021-04-05 17:02:24
Documents
5
Period of Report
2021-05-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A d41684ddef14a.htm DEF 14A 560222
2 GRAPHIC g41684g01v01.jpg GRAPHIC 246398
3 GRAPHIC g41684g02v02.jpg GRAPHIC 175412
4 GRAPHIC g41684g07d97.jpg GRAPHIC 4500
5 GRAPHIC g41684g89m19.jpg GRAPHIC 5759
  Complete submission text file 0001193125-21-106460.txt   1157069
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34375 | Film No.: 21806358
SIC: 3841 Surgical & Medical Instruments & Apparatus